Glycans are major nutrients for the human gut microbiota (HGM). Arabinogalactan proteins (AGPs) comprise a heterogenous group of plant glycans in which a β1,3-galactan backbone and β1,6-galactan side chains are conserved. Diversity is provided by the variable nature of the sugars that decorate the galactans. The mechanisms by which nutritionally relevant AGPs are degraded in the HGM are poorly understood. Here we explore how the HGM organism Bacteroides thetaiotaomicron metabolizes AGPs. We propose a sequential degradative model in which exo-acting glycoside hydrolase (GH) family 43 β1,3-galactanases release the side chains. These oligosaccharide side chains are depolymerized by the synergistic action of exo-acting enzymes in which catalytic interactions are dependent on whether degradation is initiated by a lyase or GH. We identified two GHs that establish two previously undiscovered GH families. The crystal structures of the exo-β1,3-galactanases identified a key specificity determinant and departure from the canonical catalytic apparatus of GH43 enzymes. Growth studies of Bacteroidetes spp. on complex AGP revealed 3 keystone organisms that facilitated utilization of the glycan by 17 recipient bacteria, which  included B. thetaiotaomicron. A surface endo-β1,3-galactanase, when engineered into B. thetaiotaomicron, enabled the bacterium to utilize complex AGPs and act as a keystone organism.
T he human gut microbiota (HGM) contributes to the physiology and health of its host 1 . Glycans, the major nutrients for the HGM, are degraded primarily by Bacteroides species within this ecosystem 2-4 . Understanding glycan utilization in the HGM underpins prebiotic and probiotic strategies that promote human health. Glycan degradation is mediated by carbohydrate active enzymes (CAZymes), primarily glycoside hydrolases (GHs) and polysaccharide lyases (PLs) 5 , which are grouped into sequence-based families on the CAZy database (http://www. cazy.org/) 6 . Although there is structural and catalytic conservation within families, substrate specificity may vary 7 . Genes encoding glycan-degrading systems are upregulated by the target carbohydrate and are physically linked within polysaccharide utilization loci (PULs) 8, 9 . Glycan depolymerization is generally initiated by bacterial surface endo-acting GHs/PLs, and the oligosaccharides generated are imported into the periplasm and further metabolized [9] [10] [11] .
A ubiquitous component of the human diet is arabinogalactan proteins (AGPs). These proteoglycans are in every taxonomic plant group 12 , with high concentrations in processed foods such as red wine and instant coffee 13, 14 . Gum arabic AGP (GA-AGP) is widely used in the food industry to improve biophysical properties of many products 15 . AGPs comprise a β1,3-galactan backbone with β1,6-galactan side chains, which contain carbohydrate decorations ( Fig. 1a,b ). Glycans, comprising 90% of AGPs, are O-linked to hydroxyprolines in the protein component 16 . AGP utilization is poorly understood. Oligosaccharide side chains are released by GH43 subfamily 24 (GH43_24) exo-acting β1,3-galactanases 17 ; however, the mechanism for their unusual substrate specificity remains unclear. Although endo-acting enzymes contribute to glycan degradation, the role of endo-galactanases in AGP metabolism is unknown. While some enzymes that target AGPs have been described 18, 19 , models for the degradation of these glycoproteins are lacking. The prebiotic potential of GA-AGP is evident 20 ; however, fulfilling the health benefit of these glycans requires a deeper understanding of how these proteoglycans are metabolized by the HGM.
Here we report a model for simple and complex AGP utilization by Bacteroides species of the HGM. We reveal mechanisms of substrate specificity and catalysis of exo-acting β1,3-galactanases. Strategies for removing the l-rhamnopyranose (Rhap) cap of complex AGPs were shown to influence synergetic interactions between side-chain-degrading GHs and PLs. Critically, the cellular location of the endo-β1,3-galactanase defined whether a bacterium was a keystone organism, or a recipient of AGP-derived oligosaccharides.
results
Functional significance of PUL AGPS and PUL AGPL in B. thetaiotaomicron. Previous data identified two PULs (PUL AGPL and PUL AGPS ) upregulated when Bacteroides thetaiotaomicron was cultured on larchwood AGP (LA-AGP) (Fig. 1a,c) 21 . Here we showed that only PUL AGPS was substantially activated by GA-AGP (Supplementary   BT0262  BT0263  BT0264  BT0265  BT0266 BT0267  BT0268  B T0269  B T0270  B T0271  B T0272   BT0273  BT0274  BT0275  BT0276  BT0277  BT0278  BT0279  BT0280  BT0284  BT0285  BT0290   BT3674  BT3675 BT3676  BT3677  BT3678  BT3679  BT3680  BT3681  BT3682  BT3683  BT3685  BT3686  BT3687   BT0291   HP  PL27  HP  HP  HP   HP  HP  Prot  HP  HP  HP  HP  HP  HP   HP  HP  HP  HP  GH145   GH43  GH43   GH43  GH43  GH43  GH105 arabinogalactans, and the enzymes that act on these glycans. The enzymes are identified by their locus tag (BTXXXX and BaccellXXXX are derived from B. thetaiotaomicron and B. cellulosilyticus, respectively), assignment to CAZy families (GHXX and PLXX indicate glycoside hydrolase and polysaccharide lyase families, respectively) and their predicted cellular location (based on the nature of the signal peptide and, in some cases, cellular location for the observed activity, proteomic analysis or resistance to proteinase K; see Fig. 5a ,e,f), in which superscript P and C indicate periplasmic and cytoplasmic location, respectively. The black arrows show the linkage cleaved by the enzymes, although the polysaccharide lyase activity of BT0263 is not functionally relevant as it is located in the cytoplasm. We propose that the β-l-arabinofuranose targeted by BT3674 is linked to the β1,3-galactan backbone at O2 or O4. This assumption is based on the observation that the enzyme potentiates the exo-β-1,3-galactosidases that sequentially remove galactose units from the backbone (see Fig. 3a ). These galactosidases can target galactose residues decorated at O6 but not at O2 or O4. c, Schematic of B. thetaiotaomicron PULs upregulated by arabinogalactan degradation. Fig. 1a ), suggesting that different molecules activate the two PULs. Growth studies of mutants of B. thetaiotaomicron lacking the two AGP PULs showed that ΔPUL AGPL failed to grow on LA-AGP but displayed growth on GA-AGP treated with endo-β1,3-galactanases ( Supplementary Fig. 2 ). ΔPUL AGPS grew on LA-AGP but poorly on treated GA-AGP ( Supplementary Fig. 2 ). These data suggest that the two PULs orchestrate the degradation of different AGPs. To explore the biochemical basis for these phenotypes, the specificities of the enzymes encoded by these loci were determined ( Supplementary  Table 1 ). Models for metabolism of selected AGPs were generated ( Fig. 1a,b ).
Cleavage of the galactan backbone.
Based on known activities within GH families, the β-1,3-galactan backbone is predicted to be depolymerized by GH43 subfamily 24 (GH43_24) 22 and/or GH16 23 enzymes. Thus, activity of B. thetaiotaomicron GH43_24 enzymes (BT0264, BT0265, BT3683 (also contains a GH16 module) and BT3685) encoded by PUL AGPL and PUL AGPS were evaluated against d-galactose (Gal) disaccharides, LA-AGP, GA-AGP and linear β-1,3-galactan. On the basis of activity against disaccharides ( Supplementary Table 2 ), and an active-site pocket (BT3683 and BT0265) in which O3 of bound Gal was not solvent-exposed ( Fig. 2c,d ), BT0265, BT3683 and BT3685 are exo-acting β-1,3-galactosidases. BT0265 and BT3683 were active against LA-AGP and GA-AGP releasing oligosaccharide side chains ( Fig. 3a -c). Table 3 ) showed that only the GH43_24 module contributed to the observed activity of BT3683. Consistent with other GH43_24 β-1,3-galactosidases 17 , the oligosaccharides generated by BT0265 and BT3683 probably comprise β-1,6-galactooligosaccharide side chains. This assumption suggests that, in BT0265 and BT3683, O6 of the Gal backbone units bound in the active site was solvent-exposed, enabling side-chain accommodation. BT3685 was more active against β-1,3-galactobiose than the other GH43_24 enzymes, but was inactive against the AGPs tested. The role of the enzyme in degrading AGPs is unclear. The GH43_24 enzyme BT0264 was inactive against galactobiose, released oligosaccharides from LA-and GA-AGP, and generated a range of oligosaccharides from β1,3-galactan with the smaller products increasing with time ( Fig. 3d) ; consistent with endo-activity.
Mutational analyses (Supplementary

Synergistic interactions in the degradation of the β-1,3-galactan backbone.
In addition to O6-linked side chains, the AGP backbones contain sugar pendants at O2 or O4, commonly β-l-Araf units. These substitutions block progression of the exo-β1,3-galactanases through steric constraints (Fig. 2) . Mechanisms for relieving these 'roadblocks' include removal of these decorations and/or The electron density of the terminal α-Gal was too weak to model the sugar. The red dashes show the polar interactions between the ligand and both side chains and backbone N and O. Residues that make polar contacts with the side chain of the ligand are also shown. c, An overlay of the residues in BT0265 (cyan), BT3683 (green) and the GH43_24 β1,3-galactosidase Cthe_1271 (grey; PDB code 3VSZ) that interact with galactose (yellow) in complex with BT3683. d, BT3683 in complex with galactose (Gal), deoxygalactonojirimycin (DNJ) and galacto-imidazole (Gal-Im). Direct polar interactions between enzyme and ligand are indicated by black dashes and the indirect water-mediated hydrogen bonds are indicated by magenta dashes. The red dashed line represents the polar interaction between the catalytic acid (Glu 520) and Ser 487. The two conformations of Glu 520 in the Gal-Im complex are denoted by a and b.
endo-cleavage of the backbone creating non-reducing termini downstream of O2/O4 decoration. To explore these hypotheses, GA-and LA-AGP were incubated with BT3674, which contains an active site typical of β-l-arabinofuranosidases ( Supplementary  Fig. 3 ). The enzyme released arabinose from LA-AGP, mediating an eightfold increase in oligosaccharides generated by the exo-β1,3-galactanases ( Fig. 3a) . The endo-β1,3-galactanase BT0264 also increased the activity of the exo-β1,3-galactanases ( Fig. 3b,c) . Thus, B. thetaiotaomicron exploits two mechanisms to reduce stalling of exo-β1,3-galactanases.
Crystal structures of GH43_24 enzymes. The crystal structures of BT0265 and BT3683 revealed that both exo-β-1,3-galactosidases displayed a five-bladed β-propeller fold ( Fig. 2a ) typical of GH43 enzymes 24 . Typical of GH43 exo-glycosidases, the active-site pocket of BT0265 and BT3683 is in the centre of the β-propeller 24 . Ligand complexes revealed the polar interactions between Gal, hexasaccharide product and Gal-based inhibitors and the exo-β-1,3galactosidases ( Fig. 2b,c,d ). These polar interactions are augmented by apolar contacts with a hydrophobic platform (Trp261/Trp213 in BT3683/BT0265). Interaction of the essential glutamate, Glu 86/ Glu 87 in BT0265/BT3683 ( Supplementary Table 3 ), with the axial O4 of Gal ( Fig. 2b,d ) confers selectivity for Gal over Glc, and is thus a key specificity determinant. O3 of bound ligands points into the activesite pocket, explaining the exo-and not endo-activity of the β1,3galactanases. The lack of interactions with substrate outside the active site indicates that complementarity of the helical conformation of β1,3-galactan 25 and topology of the catalytic centre drives specificity. The BT0265 hexasaccharide product complex reveals that O6 of Gal in the active site is solvent-exposed ( Fig. 2b) . This explains the products generated when different enzyme combinations (signified by BTXXXX) were incubated with different AGPs. The AGPs were at 5 mg ml −1 for all reactions except BT0264 against LA-AGP and BT3683 against GA-AGP, when the substrate concentration was increased to 25 mg ml −1 ; the β-1,3-galactan backbone was at 1.5 mg ml −1 .The enzyme concentration was 1 µM. Reactions were incubated for 16 h in 20 mM sodium phosphate buffer pH 7.0 containing 150 mM NaCl. The data shown are representative of three independent replicates. a reveals how the GH127 β-l-arabinofuranosidase BT3674 acts in synergy with the exo-β1,3-galactosidases BT0265 and BT3683 on LA-AGP. The synergy between the endo-β1,3-galactanase with BT0265 and BT3683 acting on LA-AGP and GA-AGP is shown in b and c, respectively. d, A time course of BT0264 acting on β-1,3-galactan. Peaks containing a defined galactooligosaccharide are identified by a yellow circle with the degree of polymerization shown in subscript. In b and c, the peaks corresponding to β1,6-galactobiose and β1,6-galactotriose were identified by liquid chromatography-mass spectrometry (see Supplementary Fig. 1d ), and the β1,6 linkage was revealed by sensitivity to the β1,6-galactosidase BT0290.
why the enzyme releases backbone Gal residues decorated with oligosaccharides appended at O6. Whether side chains contribute to specificity is unclear; however, elements of these decorations interact with BT0265 ( Fig. 2b) . In GH43 enzymes, the catalytic acid (glutamate) and pK a modulator (aspartate) are invariant 24 . The assignment of Glu 240 in BT3683 as the catalytic acid ( Fig. 2d ) is supported by The pentasaccharide substrate shown in a grey box was released from GA-AGP by the exo-β1,3galactosidase BT0265 and then purified by size-exclusion chromatography. Individual B. thetaiotaomicron enzymes denoted BTXXX (1 μM) were incubated successively with the pentasaccharide (5 mM) for 16 h at 37 °C in 20 mM sodium phosphate buffer, pH 7.0. a,b, Monosaccharides and oligosaccharides generated by the enzymes were identified by HPAEC pulsed amperometric detection (PAD). The data in a and b show that the pentasaccharide could be degraded by the enzymes that comprise the LU and RG pathways, respectively. Note that the enzymes in the two pathways only functioned in the order shown. Verification of the degradative pathway was achieved by reconstituting the pathway using the individual, recombinantly expressed enzymes. The example is representative of independent replicates (n = 3). the reactivity of E240A. This variant did not hydrolyse β1,3galactobiose but hydrolysed 2,4-dinitrophenyl-β-d-Gal (Supplementary Table 3 ), consistent with requiring protonation when Gal is the leaving group but not when 2,4-dinitrophenolate (pK a 3.6) is generated. Mutation of the catalytic acid in BT3685 (E225Q) also revealed the expected impact on activity against the two substrates. GH43_24 enzymes lack the aspartate catalytic base that is invariant in other GH43 subfamilies 24 . In GH43_24, a highly conserved glutamine binds a water molecule ( Fig. 2d ) that could attack the anomeric carbon of the substrate below the plane of the ring, consistent with the inverting mechanism of BT3685 ( Supplementary Fig. 4 ). Mutation of the glutamine in BT3683 supports a catalytic role for this residue (Supplementary Table 3 ). The glutamine may form an imidic acid through tautomerization and thus function as the base, as proposed for some inverting enzymes 26 , or assist in positioning the catalytic water that attacks the anomeric centre of the substrate.
Deconstruction of the AGP side chains. The side chains released by exo-β1,3-galactosidases from GA-AGP were characterized by mass spectrometry ( Supplementary Fig. 5 ) and NMR spectroscopy ( Supplementary Fig. 6 ). The major side chains comprised oligosaccharides with a degree of polymerization of 3 to 7 ( Supplementary  Fig. 5 ). The non-reducing terminus of each oligosaccharide comprised Rhap-α1,4-GlcA-β1,6-Gal. Previous studies showed that the B. thetaiotaomicron GH145 α-l-rhamnosidase BT3686 removed Rhap, exposing GlcA 19 . Here we show that the exposed GlcA was removed by the β-glucuronidase BT3677, the founding member of GH154 ( Fig. 4 , Supplementary Fig. 7 and Supplementary Table  2 ). BT3677 was active against oligosaccharides only after removal of the terminal Rhap, and is thus exo-acting. The β-glucuronidase hydrolysed the GlcA-β1,6-Gal linkage when Gal was substituted with α-l-Ara at O3 ( Fig. 4 ) but not at O4 ( Supplementary Fig. 8) .
B. thetaiotaomicron removes the terminal disaccharide structure of GA-AGP by a rhamnosidase-glucuronidase (RG) pathway, consistent with limited growth of Δbt3686 on GA-AGP ( Supplementary  Fig. 2b ). Cell-free extracts of Δbt3686 cultured on LA-AGP failed to release Rhap from GA-AGP. These data confirm that the RG pathway operates in B. thetaiotaomicron and that the side chains 54 in LA-AGP/heparin-cultured B. thetaiotaomicron after the bacterial cells were treated with proteinase K (PK+) or untreated (PK−). Purified recombinant BT0264 was also subjected to proteinase treatment to verify that the enzyme is sensitive to the proteinase. The data show that the enzyme is resistant to the proteinase and thus is not located on the cell surface. The blot is an example of biological replicates where n = 3. Wild-type B. thetaiotaomicron (Bt) and B. thetaiotaomicron expressing Baccell00844 (Bt::Baccell00844) were cultured in 0.2 ml of minimal medium containing AGPs under anaerobic conditions. b, Growth assessed on GA-AGP and GA-AGP pre-treated with BT0264 (GA-AGP(BT0264)) or Baccell00844 (GA-AGP(Baccell00844)). c, Growth evaluated on wheat AGP (WH-AGP). In b and c, the error bars report standard errors of the mean of biological replicates (n = 4). d, HPAEC analysis of the products generated by recombinant Baccell00844 (1 μM) incubated with β-1,3-galactan for 16 h using standard conditions. The chromatographs are examples of biological replicates (n = 2). e, Bt, Bt::Baccell00844 and B. cellulosilyticus (Baccell) cells derived from cultures grown on GA-AGP were incubated with 0.5% β1,3-galactan for 16 h in phosphate-buffered saline in aerobic conditions for 16 h. Under these conditions, substrate is available only to the surface enzymes. Products released from the glycan were evaluated by TLC. The example is from n = 3 biological replicates. f, Venn diagram of the number of proteins identified unique to the surfome, the surfome and total proteome, and unique to the total proteome. Baccell00844 was unique to the surfome fraction. The 46 proteins detected only in the surfome are described in Supplementary Table 5 .
in GA-AGP are extensively capped with Rhap. The orthologues of BT3686 in B. cellulosilyticus, and other HGM Bacteroidetes species are not functional rhamnosidases as they lack the catalytic histidine 19 . B. cellulosilyticus, however, contains a rhamno-glucurono lyase (BACCELL_00875) that cleaved the Rha-α1,4-GlcA linkage, and the resultant 4,5ΔGlcA was released by an unsaturated glucuronidase 18 . Thus, B. cellulosilyticus releases the capping Rha-GlcA disaccharide through a lyase-unsaturated glucuronidase (LU) pathway. Genomic studies indicate that both routes to removing the capping disaccharide (RG and/or LU pathways) are possible in some Bacteroidetes species. The significance of deploying both pathways is discussed below.
Gal at the base of AGP β-1,6-galactan side chains can be decorated with Araf that may be capped with α-Gal. No enzyme encoded by B. thetaiotaomicron AGP PULs removed the α-Gal (discussed below). PUL AGPS also encodes a GH43 arabinofuranosidase (BT3675) active against wheat AGP (WH-AGP) ( Supplementary  Table 2 ). BT3675 hydrolysed the Araf-α1,3-Gal glycosidic bond, but not when Gal also contained α-l-Araf at O4. The two enzymes and cell-free extracts of B. thetaiotaomicron cultured on AGPs did not cleave the O4-linked Araf. Thus, B. thetaiotaomicron is unable to cleave α-Araf linked O4 to Gal.
The GH35 enzyme BT0290 hydrolysed β-1,6-galactan side chains in LA-AGP and β-1,6-galactobiose, exhibiting minor activity against β-1,3-galactobiose. The crystal structure of BT0290 revealed a (β/α) 8 barrel catalytic module. In the ligand complex, Gal is in the active-site pocket at the end of the β-barrel ( Supplementary  Fig. 9 ), which contains a pair of glutamates that comprise a canonical catalytic apparatus for a retaining enzyme, expected for GH35. The pocket extends onto a planar surface that houses the O6-linked β-Gal in the +1 subsite. Trp215 in the +1 subsite creates a steric block for O3-or O4-linked sugars and provides a hydrophobic platform for an O6-linked β-Gal. This tryptophan is probably a specificity determinant for the β-1,6-galactosidase activity of BT0290.
In vivo degradation of AGPs by HGM Bacteroidetes species.
Supplementary Table 4 reports growth profiles of type strains of 20 HGM Bacteroidetes species. All species except Dysgonomonas gadei utilized LA-AGP, while only B. cellulosilyticus, B. caccae and D. gadei grew on GA-AGP or WH-AGP (Supplementary Table 4 ). This was surprising as B. thetaiotaomicron, at least, degrades side chains from GA-AGP. The initial depolymerization of polysaccharides in Bacteroides species occurs at the bacterial surface, generating oligosaccharides suitable for transport into the periplasm 10, 11 . In B. thetaiotaomicron, the GH43_24 endo-β1,3-galactanase, BT0264, has a type I signal peptide typical of periplasmic proteins, confirmed by cell localization studies ( Fig. 5a and Supplementary Fig. 10 ). The inability of B. thetaiotaomicron to grow on GA-AGP probably reflects the absence of a surface endo-β1,3-galactanase required to generate the GA-AGP-derived oligosaccharides for import into the periplasm. This was confirmed by growth of B. thetaiotaomicron on GA-AGP and WH-AGP pre-treated with BT0264 (Fig. 5b,c and Supplementary Table 4 ). The BT0264-treated GA-AGP was also a growth substrate for the other 16 Bacteroidetes species unable to utilize intact GA-and WH-AGP (Supplementary Table 4 ). The inability of the majority of HGM-derived Bacteroidetes species to utilize GA-AGP reflects the lack of an endo-β1,3-galactanase that can degrade extracellular GA-AGP. Growth of these organisms on LA-AGP reflects the low degree of polymerization of the glycan, enabling direct import into the periplasm.
The B. cellulosilyticus genome encodes four GH16 and four GH43_24 enzymes that, potentially, comprise endo-β1,3galactanases. Reverse transcription PCR of SusC genes of three PULs encoding enzymes from these families ( Supplementary  Fig. 1b ) revealed only one locus (contains three susCs) that was significantly upregulated by AGPs ( Supplementary Fig. 1c ). Of the GH43_24 and GH16 enzymes encoded by these PULs, only Baccell00844 (GH16) degraded β1,3-galactan and is thus an endo-β1,3-galactanase ( Fig. 5d ). Baccell00844 contains a type II signal peptide, consistent with a surface location. Whole-cell assays of B. cellulosilyticus under aerobic conditions, which report only activity of surface proteins 11 , showed that β1,3-galactan was degraded into numerous oligosaccharides (Fig. 5e ). This indicates that B. cellulosilyticus displays surface endo-β1,3-galactanase activity, which is probably mediated by Baccell00844. Support for the role played by Baccell00844 is provided by growth of all the Bacteroidetes species on GA-AGP pre-treated with Baccell00844 ( Supplementary Table  4 ). An orthologue to Baccell00844 in B. caccae (BACCAC_03237) may explain its growth on GA-AGP and WH-AGP. Insertion of baccell00844 into B. thetaiotaomicron PUL AGPL (B. thetaiotaomicro n::baccell00844) enabled the bacterium to grow on intact GA-AGP and WH-AGP ( Fig. 5b,c) . B. thetaiotaomicron::baccell00844, but not wild-type B. thetaiotaomicron, degraded β1,3-galactan in aerobic whole-cell assays (Fig. 5e ), demonstrating acquisition of surface endo-β1,3-galactanase activity. Proteomic analysis of intact cells of B. thetaiotaomicron::baccell00844 revealed tryptic peptides from 46 proteins ( Fig. 5f ) that were detected only on the bacterial surface. These proteins included Baccell00844 (five tryptic peptides identified by tandem mass spectrometry (MS/MS; Supplementary Fig.  11 ). Among the 45 B. thetaiotaomicron proteins were a number that have been shown, experimentally, to be surface exposed (SusD/Clike proteins, surface CAZymes and SGBPs; Supplementary Table  5 ), and all of the polypeptides contain canonical type II signal peptides consistent with outer membrane attachment. The presence of Baccell00844 among these 46 proteins supports its proposed surface location in B. thetaiotaomicron::baccell00844. Collectively, the proteomics data and surface endo-β1,3-galactanase activity of B. thetaiotaomicron::baccell00844 demonstrate that growth of the engineered bacterium on intact GA-AGP and WH-AGP is conferred through the surface endo-β1,3-galactanase activity encoded by baccell00844.
The To establish the extent to which B. thetaiotaomicron utilizes AGP side chains, limit products generated from growth on BT0264treated GA-AGP were characterized. The major product was a hexasaccharide derived from a heptasaccharide in which the terminal rhamnose had been removed by BT3686 ( Supplementary Figs. 12  and 13 ). The inability to degrade this oligosaccharide reflects the absence of a α-galactosidase encoded by the AGP-PULs. The limit product generated by B. cellulosilyticus from GA-AGP was a tetrasaccharide, also derived from the heptasaccharide ( Supplementary  Figs. 12 and 13 ). This is consistent with the α-galactosidase gene baccell00859 in the B. cellulosilyticus AGP PUL, and removal of the Rha-GlcA cap by the LU pathway in which the unsaturated glucuronidase can target 4,5ΔGlcA-β1,6-Gal linkages in which the Gal is decorated at O3 and/or O4. Both organisms lacked an α-arabinofuranosidase that targeted O4 linkages.
Analysis of AGP-PULs in HGM Bacteroidetes species. Only
B. finegoldii contained a locus equivalent to B. thetaiotaomicron PUL AGPL , while PUL AGPs was in most species of the Bacteroides genus, with various levels of rearrangements ( Supplementary Figs.  14 and 15 ). No enzyme conservation pattern that correlated with growth on LA-AGP or GA-AGP was identified. For example, B. stercoris grows on LA-AGP but lacks the orthologous enzymes found in its closest relatives. The evolution of AGP-PULs was compared to the (16S-based) phylogenetic tree of the species ( Supplementary  Table 4 ). Closely related species have similar PUL organization, but at the single gene level there are examples of a lack of orthologues. Thus, Bacteroidetes AGP PULs are highly dynamic systems that can be rapidly lost, gained or rearranged between closely related species (see B. massiliensis and B. plebeius in comparison with B. vulgatus and B. dorei; B. cellulosilyticus compared to B. thetaiotaomicron). In consequence 16S-derived taxonomy cannot be used to predict AGP degradation in Bacteroidetes. 
Discussion
This study reveals the enzymes required to depolymerize the β1,3galactan backbone of AGPs, resulting in release of the oligosaccharide side chains. This diversity probably reflects the substituents at O2 or O4 of the backbone Gals that would limit the progressive action of the critical exo-galactanases. The data also show that the GH43 exo-β1,3-galactanases lack the catalytic base present in all other enzymes of this family. Deviation from conservation of catalytic residues in GH families is rare, although not without precedent 27 . Analysis of the enzymes that deconstruct side chains of two AGPs provides insights into the biological relevance of the AGP PULs in B. thetaiotaomicron. The inability of ΔPUL AGPL to grow on LA-AGP reflects the absence of BT0290, the β1,6-galactosidase that hydrolyses the β1,6-galactan side chains, which, in this glycan, are not extensively decorated. BT0290 is less important in degrading complex AGPs, such as GA-AGP, as the decoration of β1,6-galactan side chains with other sugars represents significant nutrients. The inability of ΔPUL AGPS to grow on GA-AGP (endo-β1,3-galactanase pre-treated) reflects extensive capping of the side chains with Rhap. Loss of the rhamnosidase gene bt3686 in PUL AGPS greatly restricts further degradation of the side chains. To summarize, PUL AGPS encodes an enzyme consortium that degrades the major side chains in complex AGPs such as GA-AGP, while PUL AGPL targets the β-1,6linked Gal side chains that are important nutrients in simpler glycans such as LA-AGP.
AGPs are diverse and numerous enzymes are required to mediate their deconstruction. Combined with recent reports 18, 19 , four CAZyme families that contribute to AGP degradation were discovered; however, further enzymes probably await discovery. Indeed, in PUL AGPL there are 14 genes encoding secreted hypothetical proteins that may contribute to degradation of complex AGPs not investigated here. Unusually, two different pathways remove the disaccharide that caps the side chains in GA-AGP. Although the more flexible LU pathway should enable more comprehensive degradation, several HGM Bacteroides species utilize the RG pathway that limits downstream processing of the oligosaccharides. The contrasting oligosaccharide utilization profiles observed between B. thetaiotaomicron and B. cellulosilyticus ( Supplementary Fig. 11 ), and predicted by differences in the AGP PULs in other Bacteroides spp. ( Supplementary  Figs. 12 and 13) , may enable coexistence of species within a common niche targeting different components of the same glycan.
The majority of Bacteroidetes species studied here were unable to utilize GA-AGP, although they grow on the glycan after backbone cleavage. Utilization of complex AGP by the HGM Bacteroidetes relies on the extracellular endo-activity of a few keystone species. This study in conjunction with recent reports 28, 29 shows that glycan cross-feeding between HGM Bacteroides species contributes to the ecology of carbohydrate utilization in this ecosystem. Nevertheless, Bacteroides glycan-degrading systems generally contain surface endo-acting enzymes that generate fragments that are imported into the periplasm 10,11 , obviating the requirement for cross-feeding to utilize the polysaccharide.
In conclusion, dissecting mechanisms by which AGPs are degraded by HGM Bacteroidetes species reveals enzyme families of potential biotechnological relevance, and shows how synthetic biology can be used to engineer organisms to degrade AGPs that are abundant in the human diet.
Methods
Cloning, expression and purification of recombinant proteins. DNAs encoding enzymes lacking their signal peptides were amplified by PCR using appropriate primers. The amplified DNAs were cloned into pET28a with an N-terminal His 6 tag using NheI and XhoI restriction sites (Supplementary Table 3 ). The genes were then expressed in E. coli BL21, or Tuner cells, transformed with the appropriate recombinant plasmids. The transformed E. coli strains were cultured in Luria broth (LB) supplemented with 10 μg ml −1 of kanamycin. Cultured cells were grown at 37 °C to mid-log phase and induced with 1 mM isopropyl β-d-1-thiogalactopyranoside at 16 °C overnight. Cells were pelleted by centrifugation at 3,836 g for 10 min and resuspended in 20 mm Tris-HCl buffer, pH 8.0, containing 300 mm NaCl. For selenomethionine-derivatized protein, the above procedure was used but adjusted as follows: E. coli B834 cells were transformed with the appropriate recombinant plasmid. Overnight 5-ml cultures, in LB, were then used to inoculate 100 ml of LB culture in a 250-ml flask, which was then grown to an OD of 0.4. A methioninedeficient medium was prepared using the Molecular Dimensions SelenoMet Medium Base (MD12-501) and SelenoMet Nutrient mixtures (MD12-502) and was used to wash the cultured B834 cells. The cells were then inoculated into 1 l of methionine-deficient media to which selenomethione was added to a final concentration of 5 mg ml −1 . Cells were collected and disrupted by sonication, and the cell-free extract was recovered by centrifugation at 25,200 g for 30 min. Recombinant proteins were purified from the cell-free extract using immobilized metal affinity chromatography using Talon, a cobalt-based matrix. Proteins were eluted from the column in Buffer A containing 100 mm imidazole. For crystallographic studies, BT0265, BT0290, BT3674 and BT3683 were further purified by size-exclusion chromatography using a Superdex S200 16/600 column equilibrated with Buffer A on a fast protein liquid chromatography system (ÄKTA FPLC; GE Healthcare). All proteins were purified to electrophoretic homogeneity as judged by SDS-PAGE.
Mutagenesis. Site-directed mutagenesis was conducted using the PCR-based QuikChange site-directed mutagenesis kit (Strategene) according to the manufacturer's instructions, using the appropriate plasmid encoding BT0290, BT3674, BT3683 and BT3685 as the template and appropriate primer pairs.
Large-scale purification of oligosaccharides. GA-AGP-derived oligosaccharides were generated by incubating 20 g of the glycan with 1 µM of the β1,3-galactosidase BT0265 or BT3683 in 20 mM sodium phosphate buffer pH 7.0 implemented with 150 mM NaCl at 37 °C for 16 h. The oligosaccharide mixture was freeze-dried and resuspended in water before being applied to a P2-BioGel (BioRad) column with a 0.22 ml min −1 flow rate. Fractions were evaluated for oligosaccharide content and purity by thin-layer chromatography (TLC). Pure fractions of defined oligosaccharides were pooled and concentrated. Oligosaccharide size was confirmed by mass spectrometry and high-performance anion exchange chromatography (HPAEC).
Chemical synthesis. The synthesis of 2,4-dinitrophenyl-β-d-galactopyranoside was as described previously 30 . the α-l-arabinofuranosidase BT3675; and the β-d-glucuronidase BT3677 were monitored by the formation of NADH, at A 340 nm using an extinction coefficient of 6,230 M −1 cm −1 , with an appropriately linked enzyme assay system. The assays were adapted from two Megazyme International assay kits; the l-arabinose/dgalactose assay kit (K-ARGA) and the α-glucuronidase assay kit (K-AGLUA). Activity on 4-nitrophenyl-glycosides was monitored at A 400 nm . The mode of action of enzymes were determined using HPAEC or TLC, as appropriate. In brief, aliquots of the enzyme reactions were removed at regular intervals and, after boiling for 10 min to inactivate the enzyme and centrifugation at 13,000g, the amount of substrate remaining or product produced was quantified by HPAEC using standard methodology. The reaction substrates and products were bound to a Dionex CarboPac PA100 (galactooligosaccharides/arabinooligosaccharides), PA1 (monosaccharides) or PA20 (polygalacturonic acid oligosaccharides) column and glycans were eluted with an initial isocratic flow of 100 mM NaOH and then a 0-200 mM sodium acetate gradient in 100 mM NaOH at a flow rate of 1.0 ml min −1 , using pulsed amperometric detection. Linked assays were checked to make sure that the relevant enzyme being analysed was rate limiting by increasing its concentration and ensuring that a corresponding increase in rate was observed. A single substrate concentration was used to calculate catalytic efficiency (k cat /K M ), and was checked to be markedly less than K M by halving and doubling the substrate concentration and observing an appropriate increase or decrease in rate. The
where V is the initial rate, and [S] and [E] are substrate and enzyme concentration, respectively. All reactions were carried out in 20 mM sodium phosphate buffer, pH 7.0, with 150 mM NaCl (defined as standard conditions) and performed in at least technical triplicates.
Electrospray ionization mass spectrometry. The molecular masses of purified oligosaccharides (in 10 mM ammonium acetate, pH 7.0) were analysed via negative-ion-mode infusion/offline electrospray ionization mass spectrometry following dilution (typically 1:1 (v/v)) with 5% trimethylamine in acetonitrile. Electrospray MS data were acquired using an LTQ-FT mass spectrometer (Thermo) with a FT-MS resolution setting of 100,000 at m/z = 400 and an injection target value of 1,000,000. Infusion spray analyses were performed on 5-10 μl of samples using medium 'nanoES' spray capillaries (Thermo) for offline nanospray mass spectrometry in negative ion mode at 1 kV.
Liquid chromatography-mass spectrometry. The sample containing the oligosaccharides generated by treatment of LA-AGP with BT0265 was diluted 1:10 (v/v) with Buffer B (85% acetonitrile/15% 50 mM ammonium formate in water, pH 4.7) and 0.5 µl was analysed by liquid chromatography-mass spectrometry analysis via elution from a ZIC-HILIC (SeQuant, 3.5 µm, 200 Å, 150 × 0.3 mm, Merck) capillary column. The column was connected to a NanoAcquity HPLC system (Waters) and heated to 35 °C with an elution gradient as follows: 100% Buffer B for 5 min, followed by a gradient to 25% Buffer B/75% Buffer A (50 mM ammonium formate in water, pH 4.7) over 40 min. The flow rate was 5 µl min −1 and 10 column volumes of Buffer B equilibration was performed between injections. MS data were collected using a Bruker Impact II QTof mass spectrometer operated in positive ion mode, 50-2,000 m/z, with capillary voltage and temperature settings of 2,800 V and 200 °C respectively, together with a drying gas flow and nebulizer pressure of 6 l min−1 and 0.4 bar. The MS data were analysed using Compass DataAnalysis software (Bruker). 1 H-NMR determination of catalytic mechanism. The enzyme BT3685 at ~20 μM was assayed using 2,4-dinitrophenyl-β-d-galactopyranoside (5 mM). The enzymes were solvent-exchanged three times by ultrafiltration in 20 mM Tris-HCl, 500 mM NaCl, pD 7.5 using D 2 O as the solvent. Substrates were repeatedly freeze dried using the same buffer and resuspended in D 2 O. Before addition of enzyme, an initial 1 H-NMR spectrum was obtained. Enzyme was added and spectra were recorded at appropriate time intervals. The emergence of individual monosaccharide product αand β-anomers in the case of BT3685 was monitored to deduce catalytic mechanism.
2D NMR and mass spectrometry of GA-AGP oligosaccharides. 1 H NMR. NMR spectra were recorded at 298 K in D 2 O with a Bruker AVANCE III spectrometer operating at 600 MHz equipped with a TCI CryoProbe. NMR chemical-shift assignments were obtained using 2D 1 H-1 H TOCSY, ROESY and DQFCOSY alongside 2D 13 C HSQC, H2BC, HMBC, HSQC-TOCSY and HSQC-ROESY experiments using established methods 32 . The mixing times were 70 ms and 200 ms for the TOCSY and ROESY experiments, respectively (data for the tetraand heptasaccharides are shown in Supplementary Fig. 4 ). Chemical shifts were measured relative to internal acetone (δ H = 2.225, δ C = 31.07 ppm). Data were processed using the Azara suite of programs (v.2.8), and chemical-shift assignment was performed using Analysis (v.2.4), as described previously 33 . The non-reducingend Rha residue was readily identified from the presence of a methyl group at the 6-position. All of the linkages were clear from downfield 13 C shifts of the linked atoms, inter-glycosidic cross-peaks in the HMBC spectrum and intense NOE cross-peaks in the ROESY spectrum. The anomeric configurations of the pyranoses were confirmed by measurement of the 1 J C-1,H-1 coupling constant (about 170 and 160 Hz for αand β-configurations, respectively 34 ) in an F1-coupled 13 C HSQC. The assignments were complete and are shown in Supplementary Table 7 .
Mass spectrometry (MS). To confirm the AGP oligosaccharide chain structure suggested by NMR, the sample was per-methylated and analysed by matrixassisted laser desorption ionization time-of-flight mass spectrometry and MS/ MS. A single high-intensity peak with m/z 1,393.5 was identified that is consistent with the composition Ara 2 RhaGal 3 GlcA. The MS/MS spectrum of this permethylated oligosaccharide is shown in Supplementary Fig. 5 . The presence of Y 1 (m/z 259.0) and 1,5 × 1 (m/z 287.0) indicates that the reducing end is Gal. The 0,4 A 4 (m/z 1,217.5) cross-ring fragment (fragment of the oligosaccharide generated by MS/MS) indicates the presence of 1,6-linkage onto the reducing end Gal. suggest the presence of 1,6-linkage between the GlcA and Gal. The 728 Da mass difference between the Y 2 and Y 1 ions suggests that there are two Gal and two Ara residues between the GlcA and the reducing end Gal. The G2 (m/z 807.1) indicates that there is a single backbone residue of Gal. The presence of the Y 2α ion (m/z 987.3), but absence of an ion corresponding to loss of a dipentose side chain, indicates that one of the side chains is a disaccharide of Gal linked to Ara. As described above, there is a terminal Gal, so this structure is Gal-Ara. Substitution of O3 and O4 but not O2 of the Gal is suggested by the presence of G2 (m/z 807.1) and 0,2 × 1 (m/z 315.0) ions. The H 2 elimination ion, which reflects loss of Rha-GlcA and Ara, suggests that an Ara is linked to O4 of the Gal, which is supported by the presence of the 3,5 A 3 (m/z 677.1). The elimination ions (G 2 , m/z 807.1; D 3 , m/z 779.1) suggest that the Gal-Ara disaccharide is linked to the O3 of the Gal on the backbone. The cross-ring fragment 0,2 × 2α (m/z 1,071.3) and elimination ion G 3α (m/z 1,113.3) suggests that the terminal Gal is not 1,2-linked to the Ara, but we were unable to locate further from the MS/MS the Gal linkage, but the results are consistent with 1,3 linkage to the Ara. The presence of this G 3α ion also indicates the furanose form of the Ara.
Growth of Bacteroides and generation of mutants. Bacteroides mutants were generated by deletion of the target gene by counter selectable allelic exchange using the pExchange-tdk plasmid. The full method is described in ref. 35 . Mutants generated in this study are distinguished by the locus tag of the gene deleted/ inactivated (Δbtxxx).
Bacteroides spp. were routinely cultured under anaerobic conditions at 37 °C using an anaerobic cabinet (Whitley A35 Workstation; Don Whitley) in culture volumes of 0.2, 2 or 5 ml) of TYG (tryptone-yeast extract-glucose medium) or minimal medium (MM) 30 containing 0.5-1% of an appropriate carbon source and 1.2 mg ml −1 porcine haematin (Sigma-Aldrich) as previously described 10 . The growth of the cultures was monitored by OD 600 nm using a Biochrom WPA cell density meter for the 5 ml cultures or a Gen5 v2.0 Microplate Reader (Biotek) for the 0.2 and 2 ml cultures.
Protein cellular localization of BT0264 using antibodies. Cellular localization of proteins was carried out as described previously 36 . In brief, B. thetaiotaomicron was grown overnight (OD 600 nm value of 2.0) in 5 ml MM containing LA-AGP. The next day, cells were collected by centrifugation at 5,000g for 10 min and resuspended in 2 ml PBS. Proteinase K (0.5 mg ml −1 final concentration) was added to 1 ml of the suspension and the other half left untreated (control). Both samples were incubated at 37 °C for 16 h followed by centrifugation (5,000g for 10 min) to collect cells. To eliminate residual proteinase K activity, cell pellets were resuspended in 1 ml of 1.5 M trichloroacetic acid and incubated on ice for 30 min. Precipitated mixtures were then centrifuged (5,000g, 10 min) and washed twice in 1 ml ice-cold acetone (99.8%). The resulting pellets were allowed to dry in a 40 °C heat block for 5 min and dissolved in 250 μl Laemmli buffer. Samples were heated for 5 min at 98 °C and mixed by pipetting several times before resolving by SDS-PAGE using 12% gels. Electrophoresed proteins were transferred to nitrocellulose membranes by western blotting followed by immunochemical detection using primary rabbit polyclonal antibodies (Eurogentec) generated against BT0264 and secondary goat anti-rabbit antibodies (Santa Cruz Biotechnology).
Proteomics. Cell surface shaving. Bacteroides cell surface digestion was performed as previously described 37 , with minor modifications. Briefly, Bacteroides cells were collected by centrifugation (3,500g, 15 min, 4 °C) and washed three times with PBS pH 7.4. Cell pellets were subsequently resuspended in surface shaving buffer (PBS pH 7.4 containing 0.25 M sucrose). Surface shaving was performed using 2 µg trypsin at 37 °C for 30 min with shaking at 100 g. Cells in surface shaving buffer without trypsin served as controls. After surface shaving, the cells were pelleted by centrifugation (10,000g, 10 min, room temperature), and the supernatants were filter-sterilized using 0.22 µm spin filters (Corning Incorporated). Sterilized supernatants were subsequently incubated for an additional 16 h at 37 °C for complete digestion. Trypsin digestion was stopped with the addition of trifluoroacetic acid at a final concentration of 1%, and peptides were desalted using Macro C18 Spin Columns (Harvard Apparatus).
Whole-cell lysate preparation. Bacteroides cells were collected and washed as described above. Cell pellets were subsequently resuspended in 8 M urea buffer in 50 mM triethylammonium bicarbonate, containing 5 mM tris(2-carboxyethyl) phosphine. Cells were lysed via sonication using an ultrasonic homogenizer (Hielscher). Proteins were subsequently alkylated for 30 min at room temperature using 10 mM iodoacetamide in the dark. Protein concentration was determined using a Bradford protein assay (Thermo Fisher Scientific). Protein samples, containing 50 µg total protein, were diluted fivefold with 50 mM triethylammonium bicarbonate and protein digestion was performed at 37 °C for 18 h with shaking at 300 r.p.m. A protein to trypsin ratio of 50:1 was used. Trypsin digestion was stopped and peptides were desalted as described above.
Mass spectrometry. Peptides were dissolved in 2% acetonitrile containing 0.1% trifluoroacetic acid, and each sample was independently analysed on an Orbitrap Fusion Lumos Tribrid mass spectrometer (Thermo Fisher Scientific), connected to a UltiMate 3000 RSLCnano System (Thermo Fisher Scientific). Peptides were injected on an Acclaim PepMap 100 C18 LC trap column (100 μm ID × 20 mm, 3 μm, 100 Å) followed by separation on an EASY-Spray nanoLC C18 column (75 ID μm × 500 mm, 2 μm, 100 Å) at a flow rate of 300 nl min −1 . Solvent A was water containing 0.1% formic acid, and solvent B was 80% acetonitrile containing 0.1% formic acid. The gradient used for analysis of surface-shaved samples was as follows: solvent B was maintained at 3% for 6 min, followed by an increase from 3 to 35% B in 43 min, 35-90% B in 0.5 min, maintained at 90% B for 5.4 min, followed by a decrease to 3% in 0.1 min and equilibration at 3% for 10 min. The gradient used for analysis of proteome samples was as follows: solvent B was maintained at 3% for 6 min, followed by an increase from 3 to 35% B in 218 min, 35-90% B in 0.5 min, maintained at 90% B for 5 min, followed by a decrease to 3% in 0.5 min and equilibration at 3% for 10 min. The Orbitrap Fusion Lumos was operated in positive-ion data-dependent mode using a modified version of the recently described charge-ordered parallel ion analysis (CHOPIN) method for synchronized use of both the ion trap and the Orbitrap mass analysers 38 . The CHOPIN method is derived from the 'Universal Method' developed by Thermo Fisher, to extend the capabilities of mass analyser parallelization. The precursor ion scan (full scan) was performed in the Orbitrap in the range of 400-1,600 m/z with a resolution of 120,000 at 200 m/z, an automatic gain control (AGC) target of 4 × 10 5 and an ion injection time of 50 ms. MS/MS spectra of doubly charged precursor ions were acquired in the linear ion trap (IT) using rapid scan mode after collision-induced dissociation (CID) fragmentation. A CID collision energy of 32% was used, the AGC target was set to 2 × 10 3 and a 300 ms injection time was allowed. Precursor ions with charge state 3-7 and with an intensity < 5 × 10 5 were also scheduled for analysis by CID/IT, as described above. Precursor ions with charge state 3-7 and with an intensity > 5 × 10 5 were, however, acquired in the Oritrap (FT) with a resolution of 30,000 at 200 m/z after high-energy collisional dissociation (HCD). An HCD collision energy of 30% was used, the AGC target was set to 1 × 10 4 and a 40 ms injection time was allowed. The number of MS/ MS events between full scans was determined on-the-fly to maintain a 3 s fixed duty cycle. Dynamic exclusion of ions within a ± 10 p.p.m. m/z window was implemented using a 35 s exclusion duration. An electrospray voltage of 2.0 kV and capillary temperature of 275 °C, with no sheath and auxiliary gas flow, was used.
Mass spectrometry data analysis. All MS/MS spectra were analysed using MaxQuant 1.5.1.7 39 , and searched against a combined database of Bacteroides thetaiotaomicron VPI-5482 (containing 4782 entries), B. cellulosilyticus MGS:158 (containing 4369 entries) and the B. cellulosilyticus BACCELL_00844 glycosyl hydrolase family 16 protein. Protein sequences were downloaded from Uniprot on 10 May 2018. Peak list generation was performed within MaxQuant and searches were performed using default parameters and the built-in Andromeda search engine 40 . The enzyme specificity was set to consider fully tryptic peptides, and two missed cleavages were allowed. Oxidation of methionine, N-terminal acetylation and deamidation of asparagine and glutamine were allowed as variable modifications. No fixed modifications were employed in searches for the surface-shaved samples, whereas carbamidomethylation of cysteine was allowed as a fixed modification in proteome searches. A protein and peptide false discovery rate of less than 1% was employed in MaxQuant. Proteins were considered confidently identified when they contained at least two unique tryptic peptides. Proteins that contained similar peptides and that could not be differentiated on the basis of MS/MS analysis alone were grouped to satisfy the principles of parsimony. Reverse hits and contaminants were removed before downstream analysis. Skyline 4.1.0.11796 was used for extraction of ion chromatograms 41 . Gene ontology enrichment was performed using PANTHER 42 and subcellular protein localization prediction was performed using LocateP v2 43 . The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with data set identifier PXD010274.
Cross-feeding and competition assays. Before co-culture, each Bacteroides spp. was grown in TYG and washed in PBS before being used to inoculate MM containing 0.5% GA-AGP. Co-cultures were grown in triplicate. Samples of 0.5 ml were taken at regular intervals during growth, which were serially diluted and plated onto brainheart infusion (Sigma-Aldrich) with agar and porcine haematin for determination of total CFUs per millilitre of the culture. Mono-cultures of each Bacteroides spp.
were also plated for determination of CFUs per millilitre at intervals during the growth. Genomic DNA was purified from the remainder of the co-culture sample (Bacterial genomic DNA purification kit, Sigma-Aldrich). Quantitative PCR was performed in triplicate on each sample using a ROCHE Lightcycler 96 to determine the ratio of each Bacteroides spp. and mutants in the sample using primers specific for unique regions in each Bacteroides sp. genome. Primers for B. thetaiotaomicron (F: 5′-AGGTGCAGGCAACCT-3′, R:5′-AATTCCCGTTCTCCATGTCC-3′), B. ovatus (F: 5′-GGAATGAGCATAATCCATATATCAAGATGAAACG-3′, R: 5′-TACCTGAAACAATCATCCTTTATTTCTGTAGC-3′), B. cellulsoylticus (F: 5′-AGCAGGCGGAATTCGATAAG-3′ R:5′-GTGTACAGTGCCAGGCATAA-3′) and B. caccae (F: 5′-GATTATGTGGACAGGTGATCGTGTGATTTC-3′, R: 5′-ATTCCACCAAATGTAGGCGGGACGTTTAAT-3′) were used to determine the ratio of each species in co-culture and used to calculate the CFUs per millilitre of each organism in the culture.
Crystal structure determination. Crystallization. BT0290-E182A at 10 mg ml −1 was crystallized from the commercial screen Morpheus (Molecular Dimensions) condition D3 (20 mM 1,6-hexanediol, 20 mM 1-butanol, 20 mM 1,2-propanediol (racemic), 20 mM 2-propanol, 20 mM 1,4-butanediol, 20 mM 1,3-propanediol, 100 mM imidazole-MES pH 6.5, 30% glycerol and 30% polyethylene glycol 4000). Apo BT0265 was crystallized at 32 mg ml −1 in 20% PEG 3350 and 0.2 M sodium/ potassium tartrate. Crystals were cryo-protected with 20% glycerol. Crystals of BT0265 Q249A were crystallized at 20 mg ml −1 , with a 200 mg ml −1 oligosaccharide mixture, in 20% PEG 3350 and 0.2 M sodium thiocyanate. Crystals were cryoprotected with paratone oil.
BT3683 was crystallized at 12.6 mg ml −1 in 20% PEG 3350, 0.2 M ammonium formate and 300 mM l-rhamnose. Crystals formed under these conditions were then back soaked, in mother liquor overnight to remove the rhamnose. These crystals were then transferred to a fresh drop and soaked with galactose, DNJ or Gal-Im, as desired, at concentrations >30 mM. These crystals were left overnight and then cryo-protected with paratone oil. Corresponding author(s): Harry J. Gilbert
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Describe whether the experimental findings were reliably reproduced.
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The randomization was not relevant in this study where only in intro assay were performed.
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Growth curves and Reat time-qPCR data were analyzed using Prism Graphpad software or Gen5 software (BioTek). NMR data was analyzed with Azara suite of programs (v. 2.8, copyright 1993-2017, Wayne Boucher and Department of Biochemistry, University of Cambridge, unpublished) and chemical shift assignment was performed using CCPNMR Analysis v2.4.
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Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All unique materials used are readily available from the authors or from standard commercial sources.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Protein cell localization was performed by immunochemical detection using primary rabbit polyclonal antibodies (Eurogentec) generated against the proteins BT0264 and BT4662 and secondary goat anti-rabbit antibodies (sc-2004, Santa Cruz Biotechnology). Primary rabbit polyclonal antibodies specificity was validated by the specific immunochemical detection of purified protein. c. Report whether the cell lines were tested for mycoplasma contamination.
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